- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ONCOLOGY INSTITUTE Aktie jetzt für 0€ handeln | |||||
| 18:06 | Earnings Outlook For The Oncology Institute | 1 | Benzinga.com | ||
| 23.07. | The Oncology Institute stock initiated with Outperform rating at Noble Capital | 17 | Investing.com | ||
| 16.07. | The Oncology Institute stock initiated with Buy rating at B.Riley | 1 | Investing.com | ||
| 16.07. | B.Riley stuft The Oncology Institute mit "Buy" ein und sieht Kursziel bei 6,00 $ | 1 | Investing.com Deutsch | ||
| 14.07. | The Oncology Institute Names Kristin England as Chief Administrative Officer | 1 | GlobeNewswire (USA) | ||
| 09.07. | The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members | 2 | Insider Monkey | ||
| 30.06. | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | 1 | Investing.com Deutsch | ||
| 30.06. | The Oncology Institute to serve as exclusive provider for Nevada Medicaid | 1 | Investing.com | ||
| 30.06. | The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada | 1 | GlobeNewswire (USA) | ||
| 06.06. | The Oncology Institute files for $50M common stock offering | 2 | Seeking Alpha | ||
| 03.06. | The Oncology Institute set to join the Russell 2000 and Russell 3000 Indexes | 4 | GlobeNewswire (USA) | ||
| 19.05. | Oncology Institute, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | BTIG sets $7 price target on The Oncology Institute stock | 2 | Investing.com | ||
| 14.05. | Oncology Institute, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 14.05. | The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance | 208 | GlobeNewswire (Europe) | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States... ► Artikel lesen | |
| 14.05. | The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer | 170 | GlobeNewswire (Europe) | CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI"), one of the largest value-based oncology groups in the United States, announced today that Dr.... ► Artikel lesen | |
| 08.05. | The Oncology Institute to Present at Upcoming ASCO Annual Meeting on High-Value Cancer Care Model Outcomes Showing Cost Savings and Lower Hospitalization Rates | 3 | GlobeNewswire (USA) | ||
| 07.05. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.04. | The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials | 2 | GlobeNewswire (USA) | ||
| 11.04. | Oncology Institute, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,120 | +3,45 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,626 | -5,30 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update | FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required
Strong... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,415 | +4,04 % | HSI Closes Midday at 24,929, Up 22 pts; HSTI Closes Midday at 5,438, Down 21 pts; KUAISHOU-W Down over 6%; CH MODERN D, BRILLIANCE CHI, YOURAN DAIRY, PA GOODDOCTOR, REALORD GROUP Hit New Highs | ||
| MOUNTAIN VALLEY MD | 0,012 | -16,22 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,220 | +0,92 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 1,010 | -0,20 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,298 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA8959792018 Trilogy AI Corp. 08.08.2025 CA88909Q1090 Tokenwell Platforms Inc. 11.08.2025 Tausch 1:1US92536C1036 Veru... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,668 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 2,910 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 5,990 | -1,64 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
| BEYOND AIR | 3,160 | +0,32 % | A Preview Of Beyond Air's Earnings | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,440 | -0,68 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR | ||
| AROVELLA THERAPEUTICS | 0,047 | -6,00 % | AROVELLA THERAPEUTICS LIMITED: Notice Under Section 708A |
Das Unternehmen ONCOLOGY INSTITUTE INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 4,110 Euro und damit -3,07 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONCOLOGY INSTITUTE INC finden Sie auf Wallstreet Online.